Continuous glucose monitoring in the treatment of obesity in patients with glycogen storage disease type Ia

Glycogen storage disease (GSD) type I is characterized by impaired production of glucose from glycogenolysis and gluconeogenesis resulting in severe hypoglycaemia and increased production of lactic acid, triglyceride and uric acid. The most common type, glycogenosis type Ia, demands a balanced, suff...

Descripción completa

Detalles Bibliográficos
Autores principales: Korljan Jelaska, Betty, Ostojić, Sanja Baršić, Berović, Nina, Kokić, Višnja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2013
Materias:
Novel Diagnostic Procedure
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965284/
https://www.ncbi.nlm.nih.gov/pubmed/24683476
http://dx.doi.org/10.1530/EDM-13-0056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965284/
https://www.ncbi.nlm.nih.gov/pubmed/24683476
http://dx.doi.org/10.1530/EDM-13-0056

Ejemplares similares